Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and can complicate the majority of cardiovascular and respiratory …

Aims To systematically assess late outcomes of acute pulmonary embolism (PE) and to
investigate the clinical implications of post-PE impairment (PPEI) fulfilling prospectively …

Background Pulmonary arterial hypertension is a progressive, fatal disease. Published
treatment guidelines recommend treatment escalation on the basis of regular patient …

6.2. 2. Wydolność wysiłkowa......................... 1147 6.2. 3. Markery biochemiczne........................
1147 6.2. 4. Kompleksowa ocena rokownicza i oszacowanie ryzyka........................... 1148 6.2 …

Pulmonary hypertension is a substantial global health issue. All age groups are affected with
rapidly growing importance in elderly people, particularly in countries with ageing …

Aims Guidelines recommend a goal-oriented treatment approach in pulmonary arterial
hypertension (PAH). The aim is to reach a low-risk profile, as determined by a risk …

In the past 2 decades, major changes have occurred in the epidemiological and treatment
landscape of pulmonary arterial hypertension (PAH). Previously regarded as a disease of …

This systematic review of literature and online reports critically appraised incidence and
prevalence estimates of pulmonary arterial hypertension and chronic thromboembolic …

Registries of patients with pulmonary arterial hypertension (PAH) have been instrumental in
characterizing the presentation and natural history of the disease and provide a basis for …

Background: The World Health Organization recognizes 5 groups of pulmonary
hypertension (PH), categorized by pathogenesis or comorbidity: 1-pulmonary arterial …